A day after the Indian drug regulator’s announcement that it has approved Covid-19 vaccines manufactured by the Serum Institute and Bharat Biotech, serious questions have been raised regarding the transparency and credibility of the approval process.
The top edit sets out some of the anomalies experts have raised suggesting that greater transparency is vital to forestall widespread mistrust in the vaccine, defeating the very purpose of this fast-tracked approval for a rapid return to normalcy. Read it here
Other views examine the assumptions in Budget-making this year, India’s rising techno-nationalism and the implications of economic coalitions with China.
As state and central governments finalise their FY22 budgets, how much higher should they assume FY22 will be over FY20, the last “normal” year before the pandemic? Neelkanth Mishra sets out the challenges in making those assessments. Read it here
The rising tide of techno-nationalism in India underlines the truth that successive governments have failed to articulate a coherent long-term vision and a clearly articulated R&D action plan with timelines and targets, writes Prosenjit Datta. Read it here
The EU-China investment agreement reveals the folly of expectations by coalitions of the willing that dealing with Chinese misadventures will be straightforward even if the US resumes leadership of the effort, says the second edit, explaining the implications for India. Read it here
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.